HCA HCA Healthcare, Inc.

NYSE · US · Healthcare · Medical Care Facilities · hcahealthcare.com

435.03USD+0.03%Mkt Cap: 96.48B $P/E: 14.581d ago

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities,…

Industry Peers

Medical Care Facilities

Screen all

FRE

Fresenius SE & Co. KGaA

$26.85BUSDP/E 15.8

THC

Tenet Healthcare Corporation

$20.89BUSDP/E 10.0

FME

Fresenius Medical Care AG

$11.75BUSDP/E 12.1

FMS

Fresenius Medical Care AG

$12.05BUSDP/E 11.7

EHC

Encompass Health Corporation

Universal Health Services, Inc.

$10.38BUSDP/E 7.2

ENSG

The Ensign Group, Inc.

LifeStance Health Group, Inc.

$4.65BUSDP/E 94.0

CON

Concentra Group Holdings Parent, Inc.

National HealthCare Corporation

$3.61BUSDP/E 25.9

OPCH

Option Care Health, Inc.

$3.50BUSDP/E 17.7

AVAH

Aveanna Healthcare Holdings Inc.

$2.70BUSDP/E 9.8

ACHC

Acadia Healthcare Company, Inc.

$2.69BUSD

GRDN

Guardian Pharmacy Services, Inc.

$2.67BUSDP/E 40.9

BKD

Brookdale Senior Living Inc.

$2.51BUSD

Pediatrix Medical Group, Inc.

$2.12BUSDP/E 12.5

Key Statistics

Company

Market Cap96.48B USD

Enterprise Value146.23B USD

Revenue (TTM)78.01B USD

Gross Profit31.37B USD

Net Income (TTM)6.78B USD

Revenue/Share345.31 USD

Last Price435.03 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees230.0K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)14.58

P/E (Forward)13.33

PEG1.31

EV/EBITDA9.29

EV/Revenue1.87

P/S1.21

P/B-14.00

EPS (TTM)29.83

EPS (Forward)32.02

52W Range

354.0040% of range556.52

52W High556.52 USD

52W Low354.00 USD

Profitability

Gross Margin41.50%

Oper. Margin15.16%

EBITDA Margin20.18%

Profit Margin8.97%

ROE-112.56%

ROA11.17%

Growth

Revenue Growth8.70%

Earnings Growth11.60%

Cash Flow & Leverage

Operating CF12.64B USD

CapEx (TTM)4.94B USD

FCF Margin4.79%

FCF Yield3.87%

Net Debt50.42B USD

Net Debt/EBITDA3.20

Balance Sheet

Debt/Equity-8.08

Current Ratio0.99

Quick Ratio0.78

Book Value/Sh-30.47 USD

Cash/Share5.22 USD

Dividends

Fwd Div Rate3.12 USD

Trail. Div Rate3.00 USD

Div. Yield0.73%

5Y Avg Yield0.77%

Payout Ratio10.06%

Ex-Div DateSep 16, 2026

Pay DateSep 30, 2026

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)454.23 USD

Upside (mean)+4.4%

Target Range380.00 USD – 579.00 USD

380.00+4.4% to mean579.00

# Analysts22

Ownership

Shares Out.221.84M

Float144.31M

Insiders16.61%

Institutions78.90%

Short Interest

Short Ratio4.8d

Short % Float4.60%

Short % Out.2.99%

Shares Short6.48M

Short (prev mo.)6.13M

Technical

SMA 50416.55 (+4.4%)

SMA 200445.96 (-2.4%)

Beta1.11

S&P 52W Chg14.58%

Avg Vol (30d)1.36M

Avg Vol (10d)1.16M

Technical Indicators

RSI (14)57.7

MACD4.2218

MACD Signal4.8689

MACD Hist.-0.6471

BB Upper442.71 USD

BB Middle427.21 USD

BB Lower411.70 USD

BB Width7.26%

ATR (14)11.96 USD

Vol Ratio (20d)0.78x